BlackRock Fund Advisors - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 72 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q3 2015. The put-call ratio across all filers is 0.41 and the average weighting 0.7%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q4 2016$7,824,000
-15.2%
446,293
+15.1%
0.00%
-50.0%
Q3 2016$9,221,000
+59.5%
387,615
+7.3%
0.00%
+100.0%
Q2 2016$5,781,000
-22.2%
361,343
+1.7%
0.00%
-50.0%
Q1 2016$7,429,000
-26.8%
355,261
-5.5%
0.00%0.0%
Q4 2015$10,152,000
+2.5%
375,984
+5.5%
0.00%
-33.3%
Q3 2015$9,905,000
+33.4%
356,429
+17.6%
0.00%
+50.0%
Q2 2015$7,426,000
+1235.6%
302,974
+897.9%
0.00%
Q1 2015$556,000
-7.0%
30,362
-6.4%
0.00%
Q4 2014$598,000
+130.0%
32,426
+19.7%
0.00%
Q3 2014$260,00027,0930.00%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q3 2015
NameSharesValueWeighting ↓
TANG KEVIN C 240,000$1,027,00095.09%
TANG CAPITAL MANAGEMENT LLC 10,049,224$43,011,0008.56%
RTW INVESTMENTS, LP 2,327,903$9,963,0000.15%
Boxer Capital, LLC 890,700$3,812,0000.13%
Tibra Equities Europe Ltd 72,600$311,0000.10%
WealthTrust Axiom LLC 25,400$108,0000.04%
GSA CAPITAL PARTNERS LLP 52,749$226,0000.02%
FIRST MIDWEST BANK TRUST DIVISION 34,231$147,0000.02%
HOLLENCREST CAPITAL MANAGEMENT 42,355$181,0000.02%
Summit Global Investments 48,500$208,0000.01%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders